{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T07:12:09Z","timestamp":1724656329346},"reference-count":8,"publisher":"FapUNIFESP (SciELO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Sa\u00fade P\u00fablica"],"published-print":{"date-parts":[[2010,4]]},"abstract":"<jats:p>Estudo do tipo caso-controle cujo objetivo foi descrever os casos e as causas de anafilaxia associada \u00e0 vacina contra sarampo, caxumba e rub\u00e9ola. Foram estudados 22 casos notificados em crian\u00e7as de Curitiba, PR, durante Campanha Nacional de Vacina\u00e7\u00e3o de 2004, que apresentaram manifesta\u00e7\u00f5es mucocut\u00e2neas. Para o controle, foram selecionadas 66 crian\u00e7as vizinhas dos casos, que n\u00e3o apresentaram sintomatologia ap\u00f3s a aplica\u00e7\u00e3o vacinal. Foram realizadas dosagens s\u00e9ricas de anticorpos para os ant\u00edgenos vacinais, IgE total e espec\u00edficas para diversos al\u00e9rgenos, e testes cut\u00e2neos. A resposta vacinal foi adequada, a dosagem de IgE espec\u00edfica e os testes cut\u00e2neos mostraram que os al\u00e9rgenos potenciais constituintes da vacina e a atopia n\u00e3o foram relacionados \u00e0s rea\u00e7\u00f5es anafil\u00e1ticas. Os testes cut\u00e2neos com a vacina e o dextrano foram positivos somente nos casos, sugerindo sensibiliza\u00e7\u00e3o por algum componente residual da vacina e poss\u00edvel rea\u00e7\u00e3o cruzada com o dextrano.<\/jats:p>","DOI":"10.1590\/s0034-89102010000200020","type":"journal-article","created":{"date-parts":[[2010,3,22]],"date-time":"2010-03-22T16:40:55Z","timestamp":1269276055000},"page":"372-376","source":"Crossref","is-referenced-by-count":5,"title":["Anafilaxia associada \u00e0 vacina contra sarampo, caxumba e rub\u00e9ola"],"prefix":"10.1590","volume":"44","author":[{"given":"Iolanda Maria","family":"Novadzki","sequence":"first","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Rosario Filho","sequence":"additional","affiliation":[{"name":"Universidade Federal do Paran\u00e1,  Brasil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents","volume":"112","author":"Bohlke K","year":"2003","journal-title":"Pediatrics","ISSN":"http:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.healthpol.2003.07.008","article-title":"MMR mass vaccination campaigns, vaccine-related adverse events, and the limits of the decision making process, in Brazil","volume":"67","author":"Cunha SC","year":"2004","journal-title":"Health Policy."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jaci.2005.01.010","article-title":"The diagnosis and management of anaphylaxis: an updated practice parameter","volume":"115","year":"2005","journal-title":"J Allergy Clin Immunol."},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1398-9995.2005.00785.x","article-title":"Epidemiology of life-threatening and lethal anaphylaxis: a review","volume":"60","author":"Moneret-Vautrin DA","year":"2005","journal-title":"Allergy","ISSN":"http:\/\/id.crossref.org\/issn\/0105-4538","issn-type":"print"},{"issue":"3","key":"ref5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1590\/S0021-75572004000400008","article-title":"Sensibiliza\u00e7\u00e3o a al\u00e9rgenos inalantes e alimentares em crian\u00e7as brasileiras e at\u00f3picas, pela determina\u00e7\u00e3o in vitro de IgE total e espec\u00edfica: Projeto Alergia (PROAL)","volume":"80","author":"Naspitz CK","year":"2004","journal-title":"J Pediatr (Rio J)."},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/archinte.164.3.317","article-title":"A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom","volume":"164","author":"Peng MM","year":"2004","journal-title":"Arch Inter Med."},{"issue":"1","key":"ref7","first-page":"10","article-title":"Vaccine allergy and pseudo-allergy","volume":"13","author":"Ponvert C","year":"2003","journal-title":"Eur J Dermatol."},{"issue":"6","key":"ref8","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1542\/peds.110.6.e71","article-title":"Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps-rubells vaccine in the United States","volume":"110","author":"Pool V","year":"2002","journal-title":"Pediatrics","ISSN":"http:\/\/id.crossref.org\/issn\/0031-4005","issn-type":"print"}],"container-title":["Revista de Sa\u00fade P\u00fablica"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rsp\/v44n2\/20.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T15:30:17Z","timestamp":1495812617000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0034-89102010000200020&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0034-89102010000200020"],"URL":"https:\/\/doi.org\/10.1590\/s0034-89102010000200020","relation":{},"ISSN":["0034-8910"],"issn-type":[{"value":"0034-8910","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}